AP PHARMA INC (SMCAP: APPA)





$1.65 -0.01 (-0.60%)
Turn On
KEY STATS
52-Week High Price
1.85
52-Week Low Price
0.38
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.07 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.77
Shares
39.38 M
Dividend Rate ($) / (%)
0.00/0.00
64%
36%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 154% - APPA has outperformed the S&P 500 by 128%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
ADOLOR CORP (ADLR) $1.46 -  $0.01(0.69%)0.07 B
LOTUS PHARMACEUTICALS (LTUS) $1.40 -  $0.03(2.10%)0.07 B
CARDIOVASCULAR SYSTEMS (CSII) $4.50 -  $0.14(3.21%)0.06 B
INHIBITEX INC (INHX) $1.04 -  $0.01(0.96%)0.06 B
NEURALSTEM INC (CUR) $1.91 -  $0.05(2.62%)0.06 B
ACHILLION PHARMACEUTICAL (ACHN) $2.37 -  $0.05(2.07%)0.06 B
POLYMEDIX INC (PYMX) $1.10 -  $0.04(3.77%)0.07 B
SERACARE LIFE SCIENCES (SRLS) $3.71 -  $0.30(8.80%)0.06 B
TRUBION PHARMACEUTICALS (TRBN) $3.86 -  $0.71(22.60%)0.07 B
WEIKANG BIO-TECH GP CO (WKBT) $2.50 -  $0.00(0.00%)0.07 B
STOCK ANALYSIS
There are currently no Stock Analysis.
APPA RELATED HEADLINES
arrow
Today's Stocks
<ul> <li>Flowserve invests in alternative energy solutions</li> <li>Bucyrus focuses on growth in China</li> <li>AP Pharma's new chemo drug</li> <li>DepoMed in Phase III for post herpetic Neuralgia</li> </ul>

Wall Street Media 11/13/2008
arrow
A.P. Pharma Reports Results for the Third Quarter 2008
A.P. Pharma Reports Results for the Third Quarter 2008

At BusinessWire 11/5/2008
arrow
A.P. Pharma to Present at Rodman & Renshaw 10th Annual Healthcare Conference on November 12
A.P. Pharma to Present at Rodman & Renshaw 10th Annual Healthcare Conference on November 12

At BusinessWire 11/3/2008
arrow
A.P. Pharma to Hold 2008 Third Quarter Financial Results Conference Call November 5
A.P. Pharma to Hold 2008 Third Quarter Financial Results Conference Call November 5

At BusinessWire 10/29/2008
arrow
A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV
A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV

At BusinessWire 9/30/2008
arrow
A.P. Pharma to Hold APF530 Phase 3 Trial Results Conference Call September 30 at 9:00 a.m. Eastern
A.P. Pharma to Hold APF530 Phase 3 Trial Results Conference Call September 30 at 9:00 a.m. Eastern

At BusinessWire 9/29/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2